Literature DB >> 23374072

Structures and free energy landscapes of the wild-type and A30P mutant-type α-synuclein proteins with dynamics.

Olivia Wise-Scira1, Ahmet Kemal Aloglu, Aquila Dunn, Isin Tuna Sakallioglu, Orkid Coskuner.   

Abstract

The genetic missense A30P mutation of the wild-type α-synuclein protein results in the replacement of the 30th amino acid residue from alanine (Ala) to proline (Pro) and was initially found in the members of a German family who developed Parkinson's disease. Even though the structures of these proteins have been measured before, detailed understanding about the structures and their relationships with free energy landscapes is lacking, which is of interest to provide insights into the pathogenic mechanism of Parkinson's disease. We report the secondary and tertiary structures and conformational free energy landscapes of the wild-type and A30P mutant-type α-synuclein proteins in an aqueous solution environment via extensive parallel tempering molecular dynamics simulations along with thermodynamic calculations. In addition, we present the residual secondary structure component transition stabilities at the atomic level with dynamics in terms of free energy change calculations using a new strategy that we reported most recently. Our studies yield new interesting results; for instance, we find that the A30P mutation has local as well as long-range effects on the structural properties of the wild-type α-synuclein protein. The helical content at Ala18-Gly31 is less prominent in comparison to the wild-type α-synuclein protein. The β-sheet structure abundance decreases in the N-terminal region upon A30P mutation of the wild-type α-synuclein, whereas the NAC and C-terminal regions possess larger tendencies for β-sheet structure formation. Long-range intramolecular protein interactions are less abundant upon A30P mutation, especially between the NAC and C-terminal regions, which is linked to the less compact and less stable structures of the A30P mutant-type rather than the wild-type α-synuclein protein. Results including the usage of our new strategy for secondary structure transition stabilities show that the A30P mutant-type α-synuclein tendency toward aggregation is higher than the wild-type α-synuclein but we also find that the C-terminal and NAC regions of the A30P mutant-type α-synuclein are reactive toward fibrillzation and aggregation based on atomic level studies with dynamics in an aqueous solution environment. Therefore, we propose that small molecules or drugs blocking the specific residues, which we report herein, located in the NAC- and C-terminal regions of the A30P mutant-type α-synuclein protein might help to reduce the toxicity of the A30P mutant-type α-synuclein protein.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23374072      PMCID: PMC3607329          DOI: 10.1021/cn300198q

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  53 in total

1.  Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with alpha-synuclein and its familial Parkinson's disease-linked mutants.

Authors:  Christophe Wersinger; Anita Sidhu
Journal:  Neurosci Lett       Date:  2003-05-15       Impact factor: 3.046

2.  Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.

Authors:  C J Barrow; M G Zagorski
Journal:  Science       Date:  1991-07-12       Impact factor: 47.728

3.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal.

Authors:  L Maroteaux; J T Campanelli; R H Scheller
Journal:  J Neurosci       Date:  1988-08       Impact factor: 6.167

5.  Mapping of a gene for Parkinson's disease to chromosome 4q21-q23.

Authors:  M H Polymeropoulos; J J Higgins; L I Golbe; W G Johnson; S E Ide; G Di Iorio; G Sanges; E S Stenroos; L T Pho; A A Schaffer; A M Lazzarini; R L Nussbaum; R C Duvoisin
Journal:  Science       Date:  1996-11-15       Impact factor: 47.728

6.  Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.

Authors:  W Kabsch; C Sander
Journal:  Biopolymers       Date:  1983-12       Impact factor: 2.505

7.  The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation.

Authors:  Jeffrey C Kessler; Jean-Christophe Rochet; Peter T Lansbury
Journal:  Biochemistry       Date:  2003-01-28       Impact factor: 3.162

8.  The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Authors:  Juan J Zarranz; Javier Alegre; Juan C Gómez-Esteban; Elena Lezcano; Raquel Ros; Israel Ampuero; Lídice Vidal; Janet Hoenicka; Olga Rodriguez; Begoña Atarés; Verónica Llorens; Estrella Gomez Tortosa; Teodoro del Ser; David G Muñoz; Justo G de Yebenes
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

9.  Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.

Authors:  Charbel E-H Moussa; Christophe Wersinger; York Tomita; Anita Sidhu
Journal:  Biochemistry       Date:  2004-05-11       Impact factor: 3.162

10.  Exploring protein native states and large-scale conformational changes with a modified generalized born model.

Authors:  Alexey Onufriev; Donald Bashford; David A Case
Journal:  Proteins       Date:  2004-05-01
View more
  19 in total

1.  Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.

Authors:  Igor F Tsigelny; Yuriy Sharikov; Valentina L Kouznetsova; Jerry P Greenberg; Wolf Wrasidlo; Cassia Overk; Tania Gonzalez; Margarita Trejo; Brian Spencer; Kori Kosberg; Eliezer Masliah
Journal:  ACS Chem Neurosci       Date:  2015-01-21       Impact factor: 4.418

2.  Familial Parkinson disease-associated mutations alter the site-specific microenvironment and dynamics of α-synuclein.

Authors:  Shruti Sahay; Dhiman Ghosh; Saumya Dwivedi; Arunagiri Anoop; Ganesh Maruti Mohite; Mamata Kombrabail; Guruswamy Krishnamoorthy; Samir K Maji
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

Review 3.  Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.

Authors:  Orkid Coskuner-Weber; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

4.  Phase transitions and structure analysis in wild-type, A30P, E46K, and A53T mutants of α-synuclein.

Authors:  Mark A Healey; Michael T Woodside; Jack A Tuszynski
Journal:  Eur Biophys J       Date:  2015-12-22       Impact factor: 1.733

5.  Arginine and disordered amyloid-β peptide structures: molecular level insights into the toxicity in Alzheimer's disease.

Authors:  Orkid Coskuner; Olivia Wise-Scira
Journal:  ACS Chem Neurosci       Date:  2013-10-08       Impact factor: 4.418

6.  Effects of Mutations on the Reconfiguration Rate of α-Synuclein.

Authors:  Srabasti Acharya; Shreya Saha; Basir Ahmad; Lisa J Lapidus
Journal:  J Phys Chem B       Date:  2015-12-04       Impact factor: 2.991

7.  Divalent copper ion bound amyloid-β(40) and amyloid-β(42) alloforms are less preferred than divalent zinc ion bound amyloid-β(40) and amyloid-β(42) alloforms.

Authors:  Orkid Coskuner
Journal:  J Biol Inorg Chem       Date:  2016-09-22       Impact factor: 3.358

8.  Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.

Authors:  Orkid Coskuner; Olivia Wise-Scira
Journal:  ACS Chem Neurosci       Date:  2013-05-17       Impact factor: 4.418

Review 9.  Computational approaches to understanding protein aggregation in neurodegeneration.

Authors:  Rachel L Redler; David Shirvanyants; Onur Dagliyan; Feng Ding; Doo Nam Kim; Pradeep Kota; Elizabeth A Proctor; Srinivas Ramachandran; Arpit Tandon; Nikolay V Dokholyan
Journal:  J Mol Cell Biol       Date:  2014-03-11       Impact factor: 6.216

10.  Effects of Zn2+ binding on the structural and dynamic properties of amyloid β peptide associated with Alzheimer's disease: Asp1 or Glu11?

Authors:  Liang Xu; Xiaojuan Wang; Xicheng Wang
Journal:  ACS Chem Neurosci       Date:  2013-09-13       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.